Calcium D3 Nycomed strawberry-watermelon tab. chewing. 500mg + 200ME # 120 (strawberry-watermelon)

Chewable tablets (orange) Round, biconvex tablets of white color with orange flavor.

May have small yellow blotches and uneven edges.

Chewable tablets (mint) Round white biconvex tablets with a mint flavor.

May have small white to grayish blotches and uneven edges.

Chewable tablets (strawberry-watermelon) Round biconvex tablets of white color with a strawberry-watermelon aroma.

May have small yellow to grayish blotches and uneven edges.

Pharmaco-therapeutic group

N4 Prevention and treatment of calcium and / or vitamin D deficiency 3.

Supplement to specific therapy and prevention of osteoporosis and its complications (bone fractures).

Application during pregnancy and during breastfeeding

Calcium-D3 Nycomed is used during pregnancy to replenish the deficiency of calcium and vitamin D3 in the body.

The total daily intake during pregnancy should not exceed 2500 mg of calcium and 4000 IU of vitamin D. Hypercalcemia due to overdose during pregnancy can have an adverse effect on the developing fetus.

Calcium-D3 Nycomed is used during lactation.

Calcium and vitamin D3 can pass into breast milk, so consideration must be given to the intake of calcium and vitamin D from other sources in the mother and baby.

Dosage form

Chewable tablets (orange), 500 mg + 200 IU. 20, 30, 50, 60, 100 or 120 tablets in a high-density polyethylene bottle, sealed with a screw cap, under which there is a ring for tearing off the sealing gasket, which provides control of the first opening. 1 bottle together with instructions for use is placed in a cardboard box. Chewable tablets (mint), 500 mg + 200 IU. 30, 60, 100 or 120 tablets per vial made of high density polyethylene, sealed with a screw cap, under which there is a ring for tearing off the sealing gasket, which provides control of the first opening. 1 bottle together with instructions for use is placed in a cardboard box. Chewable tablets (strawberry-watermelon), 500 mg + 200 IU. 30, 60, 90 or 120 tablets in a high density polyethylene bottle,sealed with a screw cap, under which there is a ring for tearing off the sealing gasket, which provides control of the first opening. 1 bottle together with instructions for use is placed in a cardboard box.

Shelf life

2.5 years.

Do not use after the expiration date.

Name ENG

CALCIUM-D3 NYCOMED

Clinical and pharmacological group

A drug that regulates the exchange of calcium and phosphorus

ATX code

Calcium supplements in combination with other medications

Dosage

500mg + 200IU

Structure

1 tablet contains calcium carbonate 1250 mg (corresponds to 500 mg of calcium), colecalciferol (vitamin D3) 200 IU

excipients: sorbitol

isomalt

povidone

magnesium stearate

aspartame, mono- and diglycerides of fatty acids.

Indications

prevention and treatment of calcium and / or vitamin D3 deficiency

addition to specific therapy and prevention of osteoporosis and its complications (bone fractures).

Storage conditions and periods

Store the bottle tightly closed at a temperature not exceeding 25 В° C.

Keep out of the reach of children!

INN / Active ingredient

Calcium carbonate, Colecalciferol

Contraindications

Hypercalcemia (increased concentration of calcium in the blood). Hypercalciuria (increased calcium in the urine). Nephrolithiasis. Hypervitaminosis D. Hypersensitivity to drug components. Hypersensitivity to soy or peanuts. Severe renal failure. Active tuberculosis. The drug in the dosage form of a tablet is not used in children under the age of 3 years. Calcium-D3 Nycomed contains aspartame, which is converted into phenylalanine in the body. Therefore, the drug should not be taken by patients with phenylketonuria. Chewable tablets (orange, mint) contain sorbitol, isomalt and sucrose. Chewable tablets (strawberry-watermelon) contain sorbitol and sucrose. The use is not recommended for patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase deficiency.

Specifications

Category

Bone metabolism

Scope of the medicinal product

Musculoskeletal system

Release form

Tablet

Manufacturer country

Norway

Package quantity, pcs

120

Minimum age from

3 years old

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Takeda

The amount of the dosage form in the primary package

120 pcs.

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Calcium-phosphorus metabolism regulator

Anatomical and therapeutic characteristics

A12AX Calcium preparations, in combination with other preparations

Dosage form

Chewable tablets, [strawberry-watermelon]

The target audience

Children

Dosage (volume) of the substance in the preparation

calcium carbonate 500 mg

Expiration date in days

912

Package weight, g

ten

Mode of application

:

Calcium-D3 Nycomed is taken orally. The tablets can be chewed or sucked and taken with meals. Prevention and treatment of calcium and / or vitamin D deficiency 3. Adults and children over 12 years old - 1 tablet 2 times a day, or 2 tablets once a day. Children from 5 to 12 years old - 1-2 tablets per day. Children from 3 to 5 years old - dosage in accordance with the doctor's recommendations. Supplement to specific therapy and prevention of osteoporosis and its complications (bone fractures). Adults - 1 tablet 2-3 times a day. Special patient groups Patients with impaired liver function: No dose adjustment is required. Patients with impaired renal function: Calcium-D3 Nycomed should not be used in severe renal failure. Elderly patients: The dose is the same as for adults. A possible decrease in creatinine clearance should be considered.Duration of treatment When used for the prevention and treatment of calcium and / or vitamin D 3 deficiency, the average duration of treatment is at least 4-6 weeks. The number of repeated courses during the year is determined individually. When used to supplement specific therapy and prevention of osteoporosis and its complications (bone fractures), the duration of treatment is determined by the doctor individually.

Information on technical characteristics, delivery set, country of manufacture